Table 1 Baseline demographics and clinical data of patients.
| Ā | Group 1 (nā=ā34) | Group 2 (nā=ā32) | Group 3 (nā=ā36) | P value | |
|---|---|---|---|---|---|
Age (year) | 69.7ā±ā8.1 | 66.1ā±ā8.1 | 66.4ā±ā7.0 | 0.108 | |
Sex (M: F) | 12 : 22 | 10 : 22 | 8 : 28 | 0.465 | |
Diabetes mellitus (%) | 7 (20.6) | 7 (21.9) | 6 (16.7) | 0.851 | |
Hypertension (%) | 15 (44.1) | 15 (46.9) | 14 (38.9) | 0.794 | |
Dyslipidemia (%) | 11 (32.4) | 4 (12.5) | 11 (30.6) | 0.124 | |
Pseudophakia (%) | 8 (23.5) | 6 (18.8) | 2 (5.6) | 0.098 | |
Axial length (mm) | 23.58ā±ā1.28 | 24.12ā±ā1.63 | 23.87ā±ā0.93 | 0.244 | |
BCVA (ETDRS) | 66.2ā±ā10.8 | 64.7ā±ā14.5 | 65.5ā±ā9.4 | 0.859 | |
CMT (µm) | 431.9ā±ā79.1 | 435.5ā±ā66.3 | 441.1ā±ā59.9 | 0.853 | |
M-chart score (°) | 0.49ā±ā0.49 | 0.40ā±ā0.32 | 0.47ā±ā0.48 | 0.694 | |
Aniseikonia (%)a | 4.04ā±ā3.57 | 5.86ā±ā4.58 | 6.09ā±ā4.22 | 0.141 | |
EIFL | Grade 1 (%) | 0 (0) | 0 (0) | 0 (0) | 0.596 |
Grade 2 (%) | 13 (38.2) | 15 (46.9) | 15 (41.7) | ||
Grade 3 (%) | 16 (47.1) | 9 (28.1) | 13 (36.1) | ||
Grade 4 (%) | 5 (14.7) | 8 (25.0) | 8 (22.2) | ||
Pattern | A (%) | 34 (100) | 0 (0) | 0 (0) | N/A |
B (%) | 0 (0) | 8 (25.0) | 9 (25.0) | ||
C (%) | 0 (0) | 12 (37.5) | 17 (47.2) | ||
D (%) | 0 (0) | 12 (37.5) | 10 (27.8) | ||